Simpson, E., Merola, J., Silverberg, J., Zachariae, R., Olsen, R., & Wollenberg, A. (2021). Safety of Specifically Targeting Interleukin 13 with Tralokinumab in Adult Patients with Moderate-To-Severe Atopic Dermatitis: Pooled Analysis of Five Randomized, Double-Blind, Placebo-Controlled Phase 3 and Phase 2 Trials. SKIN The Journal of Cutaneous Medicine, 5(1), s11. https://doi.org/10.25251/skin.5.supp.11